XML 41 R30.htm IDEA: XBRL DOCUMENT
v3.25.3

STOCKHOLDERS’ EQUITY AND STOCK-BASED COMPENSATION (Tables) | 9 Months Ended
--- | ---
Sep. 27, 2025
Equity [Abstract] |
SCHEDULE OF NON-VESTED RESTRICTED STOCK ACTIVITY | Restricted stock activity for the nine month period ended September 27, 2025 was as follows: SCHEDULE OF NON-VESTED RESTRICTED STOCK ACTIVITY
|  | Shares |  |  | Weighted Average Grant Fair Value |  |  | Fair Value |  |  | Intrinsic Value |
Non-vested at December 28, 2024 |  |  | 4,833,611 |  |  | $ | 1.19 |  |  | $ | 5,757,391 |  |  | $ | 6,718,720 |
Granted |  |  | 3,197,864 |  |  |  | 1.75 |  |  |  | 5,596,262 |  |  |  | - |
Forfeited |  |  | (1,163,113 | ) |  |  | 1.62 |  |  |  | (1,884,243 | ) |  |  | - |
Vested |  |  | (687,244 | ) |  |  | 1.53 |  |  |  | (1,051,483 | ) |  |  | - |
Non-vested at September 27, 2025 |  |  | 6,181,118 |  |  | $ | 1.36 |  |  | $ | 8,417,927 |  |  | $ | 14,092,949 |
Expected to vest |  |  | 6,050,629 |  |  |  |  |  |  |  |  |  |  |  |  |
SCHEDULE OF STOCK-BASED COMPENSATION EXPENSE | The following table summarizes stock-based compensation expense within each of the categories below as it relates to non-vested restricted common stock and stock options awards for the three and nine months ended September 27, 2025 and September 28, 2024 (no tax benefits were recognized): SCHEDULE OF STOCK-BASED COMPENSATION EXPENSE
|  | Three Months Ended |  |  | Three Months Ended |  |  | Nine Months Ended |  |  | Nine Months Ended |
|  | September 27, 2025 |  |  | September 28, 2024 |  |  | September 27, 2025 |  |  | September 28, 2024 |
Cost of product revenues |  | $ | 164,502 |  |  | $ | 368,312 |  |  | $ | 390,508 |  |  | $ | 857,236 |
Research and development |  |  | 160,647 |  |  |  | 308,792 |  |  |  | 402,712 |  |  |  | 569,701 |
Selling, general and administrative |  |  | 780,599 |  |  |  | 535,842 |  |  |  | 1,834,637 |  |  |  | 1,197,355 |
Total |  | $ | 1,105,748 |  |  | $ | 1,212,946 |  |  | $ | 2,627,857 |  |  | $ | 2,624,292 |
SCHEDULE OF STOCK OPTIONS VALUATION ASSUMPTIONS | SCHEDULE OF STOCK OPTIONS VALUATION ASSUMPTIONS
|  | Three Months Ended |  |  | Nine Months Ended |
|  | September 27, 2025 |  |  | September 27, 2025 |
Average risk-free interest rate |  |  | 4.54 | % |  |  | 4.54 | %
Expected dividend yield |  |  | None |  |  |  | None |
Expected life (average, in years) |  |  | 8.00 |  |  |  | 8.00 |
Expected volatility |  |  | 85 | % |  |  | 85 | %
Weighted average exercise price |  | $ | 1.76 |  |  | $ | 1.76 |
Weighted average fair value |  | $ | 1.16 |  |  | $ | 1.16 |
SCHEDULE OF STOCK OPTION ACTIVITY | A summary of stock option activity for the period ended September 27, 2025 is as follows: SCHEDULE OF STOCK OPTION ACTIVITY
|  | Number of Options |  |  | Weighted Average Exercise Price |  |  | Intrinsic Value |
Outstanding as of December 28, 2024 |  |  | — |  |  | $ | — |  |  | $ | — |
Granted |  |  | 591,366 |  |  | $ | 1.76 |  |  |  |  |
Outstanding as of September 27, 2025 |  |  | 591,366 |  |  | $ | 1.76 |  |  | $ | 307,510 |
Options exercisable as of September 27, 2025 |  |  | 73,921 |  |  | $ | 1.76 |  |  | $ | 38,439 |

X
- References No definition available. + Details
Name: | us-gaap_EquityAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (h)(1) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the changes in outstanding nonvested restricted stock units. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (c)(2) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 718 -SubTopic 10 -Subparagraph (f)(2) -Name Accounting Standards Codification -Paragraph 2 -Section 50 -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the change in stock options. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (c)(1) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ScheduleOfStockOptionsRollForwardTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration